Effect of AST-120 in Chronic Kidney Disease Treatment: Still a Controversy?

Publisher： Karger

E-ISSN： 2235-3186|135|3|201-206

ISSN： 1660-8151

Source： Nephron, Vol.135, Iss.3, 2016-12, pp. : 201-206

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of Oral Adsorbent AST-120 on Plasma Metalloproteinase-9 and Serum Tissue Inhibitor of Metalloproteinase-1 Concentrations in Chronic Renal Failure

By  

Nephron, Vol. 83, Iss. 2, 1999-09 ,pp. : 169-169

Karger

Access to resources Recommend Favorite

Role of Growth Hormone Deficiency and Treatment in Chronic Kidney Disease

By  

Cardiorenal Medicine, Vol. 1, Iss. 3, 2011-07 ,pp. : 174-182

Karger

Access to resources Recommend Favorite

Left Ventricular Hypertrophy in Chronic Kidney Disease Patients: From Pathophysiology to Treatment

By  

Cardiorenal Medicine, Vol. 5, Iss. 4, 2015-0 ,pp. : 254-266

Karger

Access to resources Recommend Favorite

Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients

By  

American Journal of Nephrology, Vol. 45, Iss. 3, 2017-01 ,pp. : 187-199

Karger

Access to resources Recommend Favorite

Hepatitis C Treatment in Chronic Kidney Disease Patients: The Kidney Disease Improving Global Outcomes Perspective

By  

Blood Purification, Vol. 43, Iss. 1-3, 2017-01 ,pp. : 206-209

Karger

Access to resources Recommend Favorite